The *Nba2*locus is a major genetic contribution to disease susceptibility in the (NZB × NZW)F1 mouse model of systemic lupus. We generated C57BL/6 mice congenic for this NZB locus, and these mice produced antinuclear autoantibodies characteristic of lupus. F1 offspring of congenic and NZW mice developed high autoantibody levels and severe lupus nephritis similar to (NZB × NZW)F1 mice. Expression profiling with oligonucleotide microarrays revealed only two differentially expressed genes, IFN-inducible genes *Ifi202*and *Ifi203*, in congenic mice versus control mice, and both were within the Nba2 interval. Quantitative PCR localized increased *Ifi202*expression to splenic B cells and non-T cells/non-B cells. Moreover, recent results show *Ifi202*shows inducible expression in NZB mice in response to both type I and type II IFNs, both *in vivo*and *in vitro*. Other experiments using mice with a targeted mutation of the type I IFN receptor show that this pathway is required for type I interferon-mediated responsiveness. Studies using splenic cells demonstrate that multiple subpopulations show enhanced *Ifi202*expression in response to type I IFN, and indicate that dendritic cells show the greatest increased expression of *Ifi202*. These results together with analyses of promoter region polymorphisms, strain distribution of expression, effects on cell proliferation and apoptosis, in addition to recent results characterizing responsiveness to type I and type II IFNs, implicate *Ifi202*as a candidate gene for lupus.
